Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts

Nav

General Info

Geography

United Kingdom (GBR)

Coverage type

Country

Time period covered

01/1997 - 12/2021

Data type

Scientific literature

Keywords

Alzheimer's disease and other dementias, Diabetes

Citation

Authors

Anatürk M, Patel R, Ebmeier KP, Georgiopoulos G, Newby D, Topiwala A, de Lange AG, Cole JH, Jansen MG, Singh-Manoux A, Kivimäki M, Suri S

Journal

BMJ Ment Health

Volume

Issue

Pages

1-7

Publication year

2023

Suggested citation

Anatürk M, Patel R, Ebmeier KP, Georgiopoulos G, Newby D, Topiwala A, de Lange AG, Cole JH, Jansen MG, Singh-Manoux A, Kivimäki M, Suri S. Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts. BMJ Ment Health. 2023; 26(1): 1-7.

DOI

101136bmjment2023300719

PMID

37603383

GHDx Entry last modified on: May 23, 2024

Header sites

Search form

Main menu

Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts

Nav